About Orflo
Orflo is a company based in Ketchum (United States) founded in 2003 was acquired by Gemini Bio in November 2019.. Orflo has raised $4.36 million across 3 funding rounds from investors including Gemini Bio, Broadoak Capital Partners and Research Corporation Technologies. Orflo offers products and services including Moxi GO II, Moxi V, and Moxi Z. Orflo operates in a competitive market with competitors including Cytek Biosciences, ACEA Biosciences, Accuri Cytometers, IntelliCyt and Cyntellect, among others.
- Headquarter Ketchum, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.36 M (USD)
in 3 rounds
-
Latest Funding Round
$175 K (USD), Series A
Apr 06, 2017
-
Investors
Gemini Bio
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Gemini Bio
(Nov 11, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Orflo
Orflo offers a comprehensive portfolio of products and services, including Moxi GO II, Moxi V, and Moxi Z. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Mini device for accurate cell counting and fluorescence detection.
Tool for precise cell count, size, and viability measurements.
Compact system for reliable cell counting in research.
Funding Insights of Orflo
Orflo has successfully raised a total of $4.36M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $175 thousand completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $175,000
-
First Round
First Round
(12 Nov 2013)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2017 | Amount | Series A - Orflo | Valuation |
investors |
|
| Apr, 2014 | Amount | Series A - Orflo | Valuation |
investors |
|
| Nov, 2013 | Amount | Seed - Orflo | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Orflo
Orflo has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Gemini Bio, Broadoak Capital Partners and Research Corporation Technologies. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research Corporation Technologies is engaged in licensing biomedical technologies.
|
Founded Year | Domain | Location | |
|
Investment banking services are offered in the United States.
|
Founded Year | Domain | Location | |
|
Supplement reagents for cell and gene therapy are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Orflo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orflo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orflo Comparisons
Competitors of Orflo
Orflo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, ACEA Biosciences, Accuri Cytometers, IntelliCyt and Cyntellect, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Advanced flow cytometry systems are manufactured for research applications.
|
|
| domain | founded_year | HQ Location |
Instruments for life science research are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Compact flow cytometers for cell analysis are developed and provided.
|
|
| domain | founded_year | HQ Location |
Screening solutions are provided using bead-based and cell-based assays.
|
|
| domain | founded_year | HQ Location |
Offers technology for cell analysis, purification, and processing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Orflo
Frequently Asked Questions about Orflo
When was Orflo founded?
Orflo was founded in 2003 and raised its 1st funding round 10 years after it was founded.
Where is Orflo located?
Orflo is headquartered in Ketchum, United States. It is registered at Ketchum, Idaho, United States.
Is Orflo a funded company?
Orflo is a funded company, having raised a total of $4.36M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.18M, raised on Nov 12, 2013.
What does Orflo do?
Orflo Technologies is developing and marketing instrumentation for the cell and protein analysis. Orflos instrumentation is a patent protected µFlow Cell Cassette. Through the combination of impedance (Coulter Principle) and fluorescence based flow cytometry Orflos instruments provide cell analysis by directly measuring fluorescence and cell volume simultaneously. The first product developed by Orflo is a hand-held cell counter. Later, Orflo extended single use cell counting to flow cytometry and multiplex bead-based assays for cell and protein research. After that, Moxi Flow and zEPI Flow platforms are launched which provides better cell and protein analysis; apoptosis, multiplexedflow cytometry, viability, RFP transfection efficiency checks, cell cycle, phagocytosis, multiplexed cytokine analysis.
Who are the top competitors of Orflo?
Orflo's top competitors include Cytek Biosciences, Bioaffinity technologies and Accuri Cytometers.
What products or services does Orflo offer?
Orflo offers Moxi GO II, Moxi V, and Moxi Z.
Who are Orflo's investors?
Orflo has 3 investors. Key investors include Gemini Bio, Broadoak Capital Partners, and Research Corporation Technologies.